MolecuLight Point-of-Care Wound Imaging Devices Awarded Group Purchasing Agreement with AllSpire Health GPO
Contract Awarded for Products that Bring Improvement to the Health Care Industry PITTSBURGH, PA (September 29, 2022) –MolecuLight Corp., the leader in point-of-care fluorescence imaging for the real-time detection of bacteria in wounds, announces it has been awarded a new group purchasing agreement with AllSpire Health GPO, a Mid-Atlantic GPO and a partner of HealthTrust […]
Marble named on the 2022 list of of Canada’s Top Growing Companies
Each year, the Globe and Mail recognizes Canada’s boldest entrepreneurial businesses for their meteoric growth. This year, Marble was ranked number 13 on that list. Check out the full list of companies over on the Globe and Mail
iGan Seeks Cash as Valuations Go From ‘Ridiculous’ to Reasonable
(Bloomberg) — Venture capital firm iGan Partners Inc. is raising $400 million to invest in health-care technology startups, seeking to capitalize on lower valuations for private companies after this year’s broad selloff in stocks. Toronto-based iGan is looking to raise $150 million for a 10-year fund known as iGan Fund 2 to invest in North […]
MolecuLight Featured in 8 Presentations and Posters at Wounds Australia 2022 Conference
Wide-Spread Clinical Evidence using the MolecuLightWound ImagingPlatform Demonstrates its Significant Global Adoption and Proven Utility in Wound Care Toronto, CANADA and Sydney, AUSTRALIA – (September 13, 2022) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announces that its MolecuLight wound imaging platform is featured in 8 […]
Bill Gates Is Reupping His Commitment To Alzheimer’s Research And Detection
Four years ago, Bill Gates led an effort in which he and a few other billionaires, including Jeff Bezos and MacKenzie Scott, pledged $30 million to create a new engine inside an Alzheimer’s foundation to speed up development of tests that could diagnose the disease. That funding later grew to $50 million. A company called RetiSpec, backed […]
CVS buys home healthcare group Signify Health for $8bn
Vy Ortenca Aliaj, Mark Vandevelde and James Fontanella-Khan CVS Health has agreed to buy home healthcare provider Signify Health for about $8bn, beating Amazon in a hotly contested takeover battle and opening a front in the pharmacy chain’s effort to become a diversified healthcare juggernaut. Read the full article
MolecuLight Secures Financing from BDC Canada and iGan Partners to Support its Commercial Expansion
New Financing to Meet Significant Growth in Global Demand for MolecuLight’s i:X® and DX™ Point-of-Care Imaging Devices for the Wound Care Industry Toronto, CANADA– (August 11, 2022) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announced that it has completed a financing with BDC Capital and […]
Benchmarks for growing health tech businesses
BY SOFIA GUERRA AND STEVE KRAUS After studying the performance of 50 top healthcare technology businesses, we reveal the fundamental trends and benchmarks leaders need to know about healthcare SaaS and tech-enabled services. Read the full article
Leonard A. Lauder, Bill Gates and Jeff Bezos Joined by New Partners in $100M Global Research Effort to Answer Urgent Need for Early Detection of Alzheimer’s Disease
Alzheimer’s Drug Discovery Foundation launches second phase of its Diagnostics Accelerator program, doubling efforts to accelerate promising diagnostics including blood tests, eye scans and digital tools Expanded roster of funders and partners, including NFL Players Association, Eli Lilly & Company, Biogen and Shanahan Family Foundation, reflects urgent need to develop more accessible, non-invasive tools to diagnose […]
New FDA Clearance Illustrates the Utility of the i:X to Reliably Detect Clinically Significant Bacteria that Impedes Wound Healing
TORONTO, CANADA – (June 29, 2022) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announces that it has received an expansion to its FDA 510(k) clearance for the MolecuLight i:X® imaging device’s ability to detect the location of elevated bacterial loads (>104 CFU/g) in wounds. The expanded labelling also […]
